Low-dose synthetic adrenocorticotropic hormone-analog therapy for nephrotic patients: results from a single-center pilot study

INTRODUCTION: This report describes our experience using a low-dose synthetic adrenocorticotropic hormone (ACTH) analog for patients affected by nephrotic syndrome who had not responded to or had relapsed after steroid and immunosuppressive treatments. PATIENTS AND METHODS: Eighteen adult nephrotic...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorusso, Paolo, Bottai, Anna, Mangione, Emanuela, Innocenti, Maurizio, Cupisti, Adamasco, Egidi, Maria Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4327400/
https://www.ncbi.nlm.nih.gov/pubmed/25709493
http://dx.doi.org/10.2147/IJNRD.S74349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4327400/
https://www.ncbi.nlm.nih.gov/pubmed/25709493
http://dx.doi.org/10.2147/IJNRD.S74349

Ejemplares similares